Proofpoint, Inc. (PFPT) Receives $89.63 Consensus PT from Brokerages

Shares of Proofpoint, Inc. (NASDAQ:PFPT) have been assigned an average recommendation of “Buy” from the twenty-six analysts that are currently covering the stock, MarketBeat reports. One investment analyst has rated the stock with a sell rating, three have given a hold rating and twenty-two have assigned a buy rating to the company. The average 12 month target price among brokers that have issued a report on the stock in the last year is $89.63.

Several brokerages recently issued reports on PFPT. Stifel Nicolaus began coverage on Proofpoint in a research report on Wednesday, June 7th. They set a “buy” rating and a $90.00 price objective for the company. Susquehanna Bancshares Inc began coverage on Proofpoint in a research report on Wednesday, June 7th. They set a “positive” rating and a $106.00 price objective for the company. ValuEngine upgraded Proofpoint from a “sell” rating to a “hold” rating in a research report on Friday, June 2nd. FBN Securities began coverage on Proofpoint in a research report on Monday, May 22nd. They set an “outperform” rating and a $95.00 price objective for the company. Finally, Zacks Investment Research downgraded Proofpoint from a “buy” rating to a “hold” rating in a research report on Wednesday, April 26th.

ILLEGAL ACTIVITY NOTICE: This report was first reported by BBNS and is the property of of BBNS. If you are accessing this report on another website, it was copied illegally and reposted in violation of US & international trademark & copyright legislation. The original version of this report can be accessed at https://baseballnewssource.com/markets/proofpoint-inc-pfpt-receives-89-63-consensus-pt-from-brokerages/1044174.html.

Proofpoint (NASDAQ PFPT) traded up 0.57% during midday trading on Friday, hitting $87.95. The company had a trading volume of 388,693 shares. Proofpoint has a 52-week low of $57.13 and a 52-week high of $94.33. The stock’s market cap is $3.85 billion. The stock’s 50-day moving average price is $84.49 and its 200-day moving average price is $79.01.

Proofpoint (NASDAQ:PFPT) last issued its quarterly earnings data on Thursday, April 20th. The software maker reported $0.12 earnings per share (EPS) for the quarter, topping the Thomson Reuters’ consensus estimate of $0.09 by $0.03. Proofpoint had a negative return on equity of 126.46% and a negative net margin of 25.63%. The firm had revenue of $113.30 million during the quarter, compared to the consensus estimate of $110.60 million. During the same period in the previous year, the firm posted ($0.09) EPS. The company’s quarterly revenue was up 43.4% compared to the same quarter last year. On average, equities research analysts expect that Proofpoint will post $0.59 EPS for the current fiscal year.

In related news, EVP Tracey Newell sold 8,183 shares of the stock in a transaction dated Monday, April 10th. The shares were sold at an average price of $73.83, for a total transaction of $604,150.89. Following the sale, the executive vice president now owns 26,529 shares in the company, valued at $1,958,636.07. The transaction was disclosed in a document filed with the SEC, which is available through this hyperlink. Also, EVP David Knight sold 3,000 shares of the stock in a transaction dated Tuesday, April 4th. The stock was sold at an average price of $75.38, for a total transaction of $226,140.00. Following the sale, the executive vice president now owns 12,642 shares in the company, valued at approximately $952,953.96. The disclosure for this sale can be found here. In the last 90 days, insiders sold 187,549 shares of company stock worth $15,250,544. Company insiders own 6.80% of the company’s stock.

Large investors have recently added to or reduced their stakes in the company. Ladenburg Thalmann Financial Services Inc. raised its stake in Proofpoint by 242.3% in the fourth quarter. Ladenburg Thalmann Financial Services Inc. now owns 1,578 shares of the software maker’s stock valued at $113,000 after buying an additional 1,117 shares during the period. DekaBank Deutsche Girozentrale raised its stake in Proofpoint by 400.0% in the first quarter. DekaBank Deutsche Girozentrale now owns 2,500 shares of the software maker’s stock valued at $185,000 after buying an additional 2,000 shares during the period. Envestnet Asset Management Inc. raised its stake in Proofpoint by 18.2% in the first quarter. Envestnet Asset Management Inc. now owns 2,897 shares of the software maker’s stock valued at $215,000 after buying an additional 446 shares during the period. Commerzbank Aktiengesellschaft FI acquired a new stake in Proofpoint during the first quarter valued at $220,000. Finally, Acrospire Investment Management LLC raised its stake in Proofpoint by 113.4% in the first quarter. Acrospire Investment Management LLC now owns 2,987 shares of the software maker’s stock valued at $222,000 after buying an additional 1,587 shares during the period.

Proofpoint Company Profile

Proofpoint, Inc is a security-as-a-service provider that enables large and mid-sized organizations to defend, protect, archive and govern their sensitive data. The Company’s security-as-a-service platform consists of an integrated suite of on-demand data protection solutions, including threat protection, incident response, regulatory compliance, archiving, governance, eDiscovery and secure communication.

Receive News & Ratings for Proofpoint Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Proofpoint Inc. and related companies with our FREE daily email newsletter.

 


Latest News

Hitters in Major League Baseball on Record Home Run Pace
Hitters in Major League Baseball on Record Home Run Pace
Atlanta Considering Playing Freddie Freeman at Third
Atlanta Considering Playing Freddie Freeman at Third
Injury to Gleyber Torres Adds to Questions About Yankees
Injury to Gleyber Torres Adds to Questions About Yankees
Game Winning Home Run Completes Nolan Arenado Cycle
Game Winning Home Run Completes Nolan Arenado Cycle
New York Yankees and Masahiro Tanaka Hit Hard Again
New York Yankees and Masahiro Tanaka Hit Hard Again
Victor Martinez Diagnosed with Irregular Heartbeat
Victor Martinez Diagnosed with Irregular Heartbeat


Leave a Reply

 
© 2006-2017 BBNS.